Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bürckstümmer T[au]:

A generic strategy for CRISPR-Cas9-mediated gene tagging. Lackner DH et al. Nat Commun. (2015)

Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line. Essletzbichler P et al. Genome Res. (2014)

A reversible gene trap collection empowers haploid genetics in human cells. Bürckstümmer T et al. Nat Methods. (2013)

Search results

Items: 22

1.

A small cassette enables conditional gene inactivation by CRISPR/Cas9.

Guzzardo PM, Rashkova C, Dos Santos RL, Tehrani R, Collin P, Bürckstümmer T.

Sci Rep. 2017 Dec 1;7(1):16770. doi: 10.1038/s41598-017-16931-z.

2.

Efficient generation and reversion of chromosomal translocations using CRISPR/Cas technology.

Lekomtsev S, Aligianni S, Lapao A, Bürckstümmer T.

BMC Genomics. 2016 Sep 17;17(1):739. doi: 10.1186/s12864-016-3084-5.

3.

Parallel reverse genetic screening in mutant human cells using transcriptomics.

Gapp BV, Konopka T, Penz T, Dalal V, Bürckstümmer T, Bock C, Nijman SM.

Mol Syst Biol. 2016 Aug 1;12(8):879. doi: 10.15252/msb.20166890.

4.

A generic strategy for CRISPR-Cas9-mediated gene tagging.

Lackner DH, Carré A, Guzzardo PM, Banning C, Mangena R, Henley T, Oberndorfer S, Gapp BV, Nijman SMB, Brummelkamp TR, Bürckstümmer T.

Nat Commun. 2015 Dec 17;6:10237. doi: 10.1038/ncomms10237.

5.

Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.

Essletzbichler P, Konopka T, Santoro F, Chen D, Gapp BV, Kralovics R, Brummelkamp TR, Nijman SM, Bürckstümmer T.

Genome Res. 2014 Dec;24(12):2059-65. doi: 10.1101/gr.177220.114. Epub 2014 Nov 4.

6.

A reversible gene trap collection empowers haploid genetics in human cells.

Bürckstümmer T, Banning C, Hainzl P, Schobesberger R, Kerzendorfer C, Pauler FM, Chen D, Them N, Schischlik F, Rebsamen M, Smida M, Fece de la Cruz F, Lapao A, Liszt M, Eizinger B, Guenzl PM, Blomen VA, Konopka T, Gapp B, Parapatics K, Maier B, Stöckl J, Fischl W, Salic S, Taba Casari MR, Knapp S, Bennett KL, Bock C, Colinge J, Kralovics R, Ammerer G, Casari G, Brummelkamp TR, Superti-Furga G, Nijman SM.

Nat Methods. 2013 Oct;10(10):965-71. doi: 10.1038/nmeth.2609. Epub 2013 Aug 25.

7.

Experimental characterization of the human non-sequence-specific nucleic acid interactome.

Dürnberger G, Bürckstümmer T, Huber K, Giambruno R, Doerks T, Karayel E, Burkard TR, Kaupe I, Müller AC, Schönegger A, Ecker GF, Lohninger H, Bork P, Bennett KL, Superti-Furga G, Colinge J.

Genome Biol. 2013 Jul 31;14(7):R81. doi: 10.1186/gb-2013-14-7-r81.

8.

Viral immune modulators perturb the human molecular network by common and unique strategies.

Pichlmair A, Kandasamy K, Alvisi G, Mulhern O, Sacco R, Habjan M, Binder M, Stefanovic A, Eberle CA, Goncalves A, Bürckstümmer T, Müller AC, Fauster A, Holze C, Lindsten K, Goodbourn S, Kochs G, Weber F, Bartenschlager R, Bowie AG, Bennett KL, Colinge J, Superti-Furga G.

Nature. 2012 Jul 26;487(7408):486-90. doi: 10.1038/nature11289.

PMID:
22810585
9.

SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations.

Goncalves A, Karayel E, Rice GI, Bennett KL, Crow YJ, Superti-Furga G, Bürckstümmer T.

Hum Mutat. 2012 Jul;33(7):1116-22. doi: 10.1002/humu.22087. Epub 2012 Apr 16.

PMID:
22461318
10.

Functional dissection of the TBK1 molecular network.

Goncalves A, Bürckstümmer T, Dixit E, Scheicher R, Górna MW, Karayel E, Sugar C, Stukalov A, Berg T, Kralovics R, Planyavsky M, Bennett KL, Colinge J, Superti-Furga G.

PLoS One. 2011;6(9):e23971. doi: 10.1371/journal.pone.0023971. Epub 2011 Sep 8.

11.

IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA.

Pichlmair A, Lassnig C, Eberle CA, Górna MW, Baumann CL, Burkard TR, Bürckstümmer T, Stefanovic A, Krieger S, Bennett KL, Rülicke T, Weber F, Colinge J, Müller M, Superti-Furga G.

Nat Immunol. 2011 Jun 5;12(7):624-30. doi: 10.1038/ni.2048.

PMID:
21642987
12.

Initial characterization of the human central proteome.

Burkard TR, Planyavsky M, Kaupe I, Breitwieser FP, Bürckstümmer T, Bennett KL, Superti-Furga G, Colinge J.

BMC Syst Biol. 2011 Jan 26;5:17. doi: 10.1186/1752-0509-5-17.

13.

The hepatitis C virus non-structural NS5A protein impairs both the innate and adaptive hepatic immune response in vivo.

Kriegs M, Bürckstümmer T, Himmelsbach K, Bruns M, Frelin L, Ahlén G, Sällberg M, Hildt E.

J Biol Chem. 2009 Oct 9;284(41):28343-51. doi: 10.1074/jbc.M109.038877. Epub 2009 Aug 12.

14.

The TLR-independent DNA recognition pathway in murine macrophages: Ligand features and molecular signature.

Karayel E, Bürckstümmer T, Bilban M, Dürnberger G, Weitzer S, Martinez J, Superti-Furga G.

Eur J Immunol. 2009 Jul;39(7):1929-36. doi: 10.1002/eji.200939344.

15.

An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome.

Bürckstümmer T, Baumann C, Blüml S, Dixit E, Dürnberger G, Jahn H, Planyavsky M, Bilban M, Colinge J, Bennett KL, Superti-Furga G.

Nat Immunol. 2009 Mar;10(3):266-72. doi: 10.1038/ni.1702. Epub 2009 Jan 21.

PMID:
19158679
16.

The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response.

Soulat D, Bürckstümmer T, Westermayer S, Goncalves A, Bauch A, Stefanovic A, Hantschel O, Bennett KL, Decker T, Superti-Furga G.

EMBO J. 2008 Aug 6;27(15):2135-46. doi: 10.1038/emboj.2008.126. Epub 2008 Jun 26.

17.

The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib.

Hantschel O, Rix U, Schmidt U, Bürckstümmer T, Kneidinger M, Schütze G, Colinge J, Bennett KL, Ellmeier W, Valent P, Superti-Furga G.

Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13283-8. Epub 2007 Aug 7.

18.

An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells.

Bürckstümmer T, Bennett KL, Preradovic A, Schütze G, Hantschel O, Superti-Furga G, Bauch A.

Nat Methods. 2006 Dec;3(12):1013-9. Epub 2006 Oct 22.

PMID:
17060908
19.

Raf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replication.

Bürckstümmer T, Kriegs M, Lupberger J, Pauli EK, Schmittel S, Hildt E.

FEBS Lett. 2006 Jan 23;580(2):575-80. Epub 2005 Dec 29.

20.

Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor.

Seifert R, Wenzel-Seifert K, Burckstummer T, Pertz HH, Schunack W, Dove S, Buschauer A, Elz S.

J Pharmacol Exp Ther. 2003 Jun;305(3):1104-15. Epub 2003 Mar 6.

PMID:
12626648
22.

Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonists.

Kelley MT, Bürckstümmer T, Wenzel-Seifert K, Dove S, Buschauer A, Seifert R.

Mol Pharmacol. 2001 Dec;60(6):1210-25.

PMID:
11723228

Supplemental Content

Loading ...
Support Center